Treatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis

Background: Although clinical practice guidelines for the management of Immune Checkpoint Inhibitor (ICI)-related adverse events have recently been published, precise and nuanced toxicity data for combination ICI therapy are lacking. Therefore, herein we have conducted a systematic review and meta-a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Robin Park, Laercio Lopes, Cagney R. Cristancho, Ivy M. Riano, Anwaar Saeed
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-03-01
coleção:	Frontiers in Oncology
Assuntos:	combination therapy immune checkpoint inhibitor anti-PD-1 anti-PD-L1 anti-CTLA-4 treatment-related adverse events
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fonc.2020.00258/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!